Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones

Journal of Cellular Biochemistry

Volumn 107, Issue 4, 2009, Pages 667-676

  Maia, Cláudio ^a   Santos, Cecília ^a   Schmitt, Fernando ^b,c   Socorro, Silvia ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

17 estradiol; Alternative transcripts; Breast; Calcium; DHT; Prostate; Regucalcin; SMP30

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN RECEPTOR; FLUTAMIDE; FULVESTRANT; MESSENGER RNA; REGUCALCIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADAL STEROID HORMONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROSTATIC NEOPLASMS;

EID: 67650087642     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22158     Document Type: Article

References (54)

1. Audy MC, Vacher P, Duly B. 1996. 17 beta-estradiol stimulates a rapid Ca2+ influx in LNCaP human prostate cancer cells. Eur J Endocrinol 135:367-373. (Pubitemid 26348743)
2. Capiod T, Shuba Y, Skryma R, Prevarskaya N. 2007. Calcium signalling and cancer cell growth. Subcell Biochem 45:405-427.
3. Cascio S, Bartella V, Garofalo C, Russo A, Giordano A, Surmacz E. 2007. Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 282:3498-3506. (Pubitemid 47084426)
4. Debes JD, Tindall DJ. 2002. The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 187:1-7. (Pubitemid 35279326)
5. Elchuri S, Naeemuddin M, Sharpe O, Robinson WH, Huang TT. 2007. Identification of biomarkers associated with the development of hepatocellular carcinoma in CuZn superoxide dismutase deficient mice. Proteomics 7:2121-2129. (Pubitemid 47020343)
6. Feng D, Kondo Y, Ishigami A, Kuramoto M, Machida T, Maruyama N. 2004. Senescence marker protein-30 as a novel antiaging molecule. Ann NY Acad Sci 1019:360-364. (Pubitemid 38951335)
7. Fujita T, Uchida K, Maruyama N. 1992. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1116:122-128.
8. Fujita T, Inoue H, Kitamura T, Sato N, Shimosawa T, Maruyama N. 1998. Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 250:374-380. (Pubitemid 28463885)
9. Govind AP, Thampan RV. 2003. Membrane associated estrogen receptors and related proteins: Localization at the plasma membrane and the endoplasmic reticulum. Mol Cell Biochem 253:233-240. (Pubitemid 37321730)
10. Huang JK, Jan CR. 2001. Mechanism of estrogens-induced increases in intracellular Ca(2+) in PC3 human prostate cancer cells. Prostate 47:141-148.
11. Inagaki S, Yamaguchi M. 2001. Regulatory role of endogenous regucalcin in the enhancement of nuclear deoxyribonuleic acid synthesis with proliferation of cloned rat hepatoma cells (H4-II-E). J Cell Biochem 82:704-711. (Pubitemid 32720685)
12. Ishigami A, Handa S, Maruyama N, Supakar PC. 2003. Nuclear localization of senescence marker protein-30, SMP30, in cultured mouse hepatocytes and its similarity to RNA polymerase. Biosci Biotechnol Biochem 67:158-160. (Pubitemid 39260158)
13. Ishigami A, Kondo Y, Nanba R, Ohsawa T, Handa S, Kubo S, Akita M, Maruyama N. 2004. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 315:575-580. (Pubitemid 38229382)
14. Ishigami A, Fujita T, Inoue H, Handa S, Kubo S, Kondo Y, Maruyama N. 2005. Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cells. Cell Tissue Res 320:243-249. (Pubitemid 40684750)
15. Isogai M, Yamaguchi M. 1995. Calcium administration increases calcium-binding protein regucalcin concentration in the liver of rats. Mol Cell Biochem 143:53-58.
16. Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA. 2003. Androgen receptor activity at the prostate specific antigen locus: Steroidal and non-steroidal mechanisms. Mol Cancer Res 1:385-392. (Pubitemid 36437924)
17. Kent WJ. 2002. BLAT-the BLAST-like alignment tool. Genome Res 12:656-664.
18. Kim J, Kim SH, Lee SU, Ha GH, Kang DG, Ha NY, Ahn JS, Cho HY, Kang SJ, Lee YJ, Hong SC, Ha WS, Bae JM, Lee CW, Kim JW. 2002. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23:4142-4156. (Pubitemid 36131469)
19. Kim W, Oe Lim S, Kim JS, Ryu YH, Byeon JY, Kim HJ, Kim YI, Heo JS, Park YM, Jung G. 2003. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res 9:5493-5500. (Pubitemid 37499467)
20. Kim N, Shin S, Lee S. 2005. ECgene: Genome-based EST clustering and gene modeling for alternative splicing. Genome Res 15:566-576. (Pubitemid 41057819)
21. Kurota H, Yamaguchi M. 1996. Steroid hormonal regulation of calcium-binding protein regucalcin mRNA expression in the kidney cortex of rats. Mol Cell Biochem 155:105-111. (Pubitemid 26082504)
22. Lee WJ, Monteith GR, Roberts-Thomson SJ. 2006. Calcium transport and signaling in the mammary gland: Targets for breast cancer. Biochim Biophys Acta 1765:235-255.
23. Maia CJ, Santos CR, Schmitt F, Socorro S. 2008. Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17beta-estradiol. Mol Cell Biochem 311:81-86.
24. Misawa H, Yamaguchi M. 2000. Transcript heterogeneity of the human gene for Ca2+-binding protein regucalcin. Int J Mol Med 5:283-287.
25. Misawa H, Inagaki S, Yamaguchi M. 2001. Suppression of cell proliferation and deoxyribonucleic acid synthesis in the cloned rat hepatoma H4-II-E cells overexpressing regucalcin. J Cell Biochem 84:143-149. (Pubitemid 33101517)
26. Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ. 2007. Calcium and cancer: Targeting Ca2+ transport. Nat Rev Cancer 7:519-530. (Pubitemid 46985398)
27. Murata T, Shinya N, Yamaguchi M. 1997. Expression of calcium-binding protein regucalcin mRNA in the cloned human hepatoma cells (HepG2): Stimulation by insulin. Mol Cell Biochem 175:163-168. (Pubitemid 27453350)
28. Muti P, Rogan E, Cavalieri E. 2006. Androgens and estrogens in the etiology and prevention of breast cancer. Nutr Cancer 56:247-252. (Pubitemid 46417686)
29. Nakagawa T, Sawada N, Yamaguchi M. 2005. Overexpression of regucalcin suppresses cell proliferation of cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med 16:637-643.
30. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M. 2006. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 28:705-713.
31. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
32. Platet N, Cathiard AM, Gleizes M, Garcia M. 2004. Estrogens and their receptors in breast cancer progression: A dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55-67. (Pubitemid 38781751)
33. Prevarskaya N, Skryma R, Shuba Y. 2004. Ca2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochem Biophys Res Commun 322:1326-1335. (Pubitemid 39164661)
34. Rossi AM, Picotto G, de Boland AR, Boland RL. 2002. Evidence on the operation of ATP-induced capacitative calcium entry in breast cancer cells and its blockade by 17beta-estradiol. J Cell Biochem 87:324-333. (Pubitemid 35231718)
35. Rouayrenc JF, Vignon F, Bringer J, Pujol P. 2000. Non-genomic steroid effects: Estrogen action revisited. Ann Endocrinol (Paris) 61:517-523. (Pubitemid 32055258)
36. Schmitt FC, Bento MJ, Amendoeira I. 1995. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: Correlation with paraffin embedded and frozen sections determinations. Diagn Cytopathol 13:347-351.
37. Shimokawa N, Yamaguchi M. 1992. Calcium administration stimulates the expression of calcium-binding protein regucalcin mRNA in rat liver. FEBS Lett 305:151-154.
38. Shimokawa N, Yamaguchi M. 1993a. Expression of hepatic calcium-binding protein regucalcin mRNA is mediated through Ca2+/calmodulin in rat liver. FEBS Lett 316:79-84. (Pubitemid 23029211)
39. Shimokawa N, Yamaguchi M. 1993b. Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver. FEBS Lett 327:251-255. (Pubitemid 23228561)
40. Srebrow A, Kornblihtt AR. 2006. The connection between splicing and cancer. J Cell Sci 119:2635-2641.
41. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj TA, Soreq H. 2005. Function of alternative splicing. Gene 344:1-20.
42. Tsurusaki Y, Yamaguchi M. 2000. Role of endogenous regucalcin in the regulation of Ca(2+)-ATPase activity in rat liver nuclei. J Cell Biochem 78:541-549. (Pubitemid 30620700)
43. Tsurusaki Y, Yamaguchi M. 2002. Role of endogenous regucalcin in nuclear regulation of regenerating rat liver: Suppression of the enhanced ribonucleic acid synthesis activity. J Cell Biochem 87:450-457. (Pubitemid 35231708)
44. Tsurusaki Y, Yamaguchi M. 2003. Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem 90:619-626. (Pubitemid 37243708)
45. Tsurusaki Y, Yamaguchi M. 2004. Role of regucalcin in liver nuclear function: Binding of regucalcin to nuclear protein or DNA and modulation of tumor-related gene expression. Int J Mol Med 14:277-281.
46. Venables JP. 2006. Unbalanced alternative splicing and its significance in cancer. Bioessays 28:378-386.
47. Walsh PC. 2003. Calcium intake and prostate cancer risk in a longterm aging study: The Baltimore Logitudinal Study of Aging. J Urol 170:312.
48. Yamaguchi M. 2000. Role of regucalcin in calcium signaling. Life Sci 66:1769-1780.
49. Yamaguchi M. 2005. Role of regucalcin in maintaining cell homeostasis and function (review). Int J Mol Med 15:371-389.
50. Yamaguchi M, Daimon Y. 2005. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: Involvement of intracellular signaling factors and cell cycle-related genes. J Cell Biochem 95:1169-1177. (Pubitemid 41420124)
51. Yamaguchi M, Kurota H. 1995. Expression of calcium-binding protein regucalcin mRNA in the kidney cortex of rats: The stimulation by calcium administration. Mol Cell Biochem 146:71-77.
52. Yamaguchi M, Oishi K. 1995. 17 beta-Estradiol stimulates the expression of hepatic calcium-binding protein regucalcin mRNA in rats. Mol Cell Biochem 143:137-141.
53. Yamaguchi M, Yamamoto T. 1978. Purification of calcium binding substance from soluble fraction of normal rat liver. Chem Pharm Bull (Tokyo) 26:1915-1918.
54. Yamaguchi M, Kanayama Y, Shimokawa N. 1994. Expression of calcium-binding protein regucalcin mRNA in rat liver is stimulated by calcitonin: The hormonal effect is mediated through calcium. Mol Cell Biochem 136:43-48. (Pubitemid 24299702)